• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Psychiatry Startup Talkiatry Completes $37M Series A

Share:

January 31, 2022

Tech-enabled psychiatric care startup Talkiatry has wrapped up its $37 million Series A financing round.

The company announced it had raised $20 million in funding in July. Left Lane Capital, which also participated last year, contributed the additional $17 million.

Other investors in the mental health startup include CityMD founder Dr. Richard Park, Sikwoo Capital Partners and Relevance Ventures.

WHAT IT DOES

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Patients interested in psychiatric care can complete an assessment, and an algorithm will match them to Talkiatry-employed mental healthcare providers. They can then book a virtual or in-person visit online. The company works with insurers so care can be offered in-network.

WHAT IT’S FOR

At this time, Talkiatry only operates in New York – where it operates two offices – but it plans to expand. The startup said it will use the capital from its Series A to scale its services across the U.S. with more contracts with national payers.

“Talkiatry has been successful in demonstrating our value and commitment to our insurance partners who are rewarding our approach of high-quality and responsible healthcare with national insurance contracts that cover over 200 million lives,” Cofounder and CEO Robert Krayn said in a statement. “Our team is focused on executing on the needs of our psychiatrists and insurance partners.”

MARKET SNAPSHOT

Digital and virtual mental health offerings are a popular area for investment. A report by CB Insights found funding for mental health-and-wellness companies rose 139% year-over-year in 2021. Much of that funding was early-stage, leaving room for growth as the field expands.

Other companies in the space include Lyra Health, an employer-focused digital mental health company that recently announced it had raised $235 million in a Series F round. In September, it revealed a suite of tools aimed at complex conditions like alcohol use disorder and suicidality.

Quartet Health also works to match patients to mental health providers based on their preferences, needs and insurance. It recently scored $60 million in funding and acquired virtual behavioral health provider InnovaTel Telepsychiatry.

Late last year, UpLift raised $8 million to add psychiatric care services to its offerings. The company allows for in-person or virtual appointments, and it’s working to expand its geographic footprint this year.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Dascena Receives FDA EUA for COVID-19 Hemodynamic Instability and Respiratory Decompensation Prediction System
  • Executive Insights: Top Healthcare Predictions & Trends to Watch in 2020Executive Insights: Top Healthcare Predictions & Trends to Watch in 2020
  • Augmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health AssetsAugmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health Assets
  • Azilect Market Insights, Global Research and Clinical Survey Report 2021-2026Azilect Market Insights, Global Research and Clinical Survey Report 2021-2026
  • Obesity Pipeline Insight Report 2021
  • EHR Vendor Cerner Eyes Developing a $1 Billion Data BusinessEHR Vendor Cerner Eyes Developing a $1 Billion Data Business
  • PharmaDrug Inc. Closes Acqusition of Securedose SyntheticsPharmaDrug Inc. Closes Acqusition of Securedose Synthetics
  • R2G Report: Digital Diabetes Market Will be Worth €1.3BN By 2024R2G Report: Digital Diabetes Market Will be Worth €1.3BN By 2024

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications